Vancouver, British Columbia / TheNewswire / September 7, 2018 – AREV Nutrition Sciences Inc. ("AREV" or the “Company”) (CSE - AREV), is pleased to announce it has completed the previously announced asset purchase and sale agreement (the “Acquisition Agreement”) dated July 3, 2018 with Matthew Harvey carrying on business under the branding “BC Bud Depot” (“BCBD”), and received CSE approval, to acquire 100% of the assets under the BCBD brand in consideration for issuance of 9,500,000 common shares of the Company at a deemed price of $0.50 per share and $500,000, of which $50,000 is payable in cash and $450,000 is payable by way of a convertible debenture (the “Convertible Debenture”) issued by the Company accruing interest at 8% per annum, for an aggregate value of $5,250,000. The outstanding principal amount and outstanding accruing interest of the Convertible Debenture shall be convertible into common shares of the Company at the price of $0.50 per common share.

 

The BCBD assets comprises breeding methodologies for new cannabis strains available for license to licensed producers for replication and further processing activities and capabilities and technologies for the development of further breeding methodologies. The BCBD assets have a large collection of breeding methodologies developed over many years in the creation of a variety of marijuana strains. BCBD specializes in launching new strains, generating initial interest and demand, and market testing based on public perception over time.

 

BCBD holds one of the world’s largest seed banks and has won over 40 awards over the past 14 years since becoming the first Canadian company in history to win as Top Strain at international competition, in 2004 with BC God Bud.

 

BC Bud Depot has won many awards in recent years and is recognized as an industry leader in the pursuit of the perfection of the cannabis gene pool. BC Bud Depot constantly strives in refining selection and breeding processes to produce the best marijuana seeds that bring you the very strongest smoke and most powerful flavor.

Here is what our award cabinet holds so far:

 

Year	Event	Award	Strain
2018 2017 2016	Kootenay Cannabis Cup Canadian Cannabis Awards Bio Cup Canada	#1 Overall Cup #3 Sativa Cup #1 PG Indica Cup	Sweet God Blue Dream Shiatsu Kush
2016	Bio Cup Canada	#1 CBD Concentrate Cup	Texada Timewarp
2015	Top 10 Strains of the Year	Top Strain	Night Nurse
2015	Kush Cup	#1 Overall Cup	BC Blueberry
2015	Bio Cannabis Cup	#1 Indica Cup	God's Gift
2014	HighTimes Cannabis Cup	#3 Hybrid Cup	Night Nurse
2014	Top 10 Strains of the Year	Top Strain	CBD God
2014	Bio Cannabis Cup	#3 Indica Cup	Harmony
2014	Cali Cup	#1 Concentrate Cup	BC Blueberry
2013	Top 10 Strains of the Year	Top Strain	Chem Fire
2013	Uruguay Cannabis Cup	#1 International Cup	Chem Fire
2013	Los Angeles Medical Cannabis Cup	#1 Hybrid Cup	Girl Scout Cookies
2012	Top 10 Strains of the Year	Top Strain	Shiatsu Kush
2012	Treating Yourself Medical Cup	#3 Sativa Cup	Sweet Island Skunk
2011	Top 10 Strains of the Year	Top Strain	The Big
2011	Prairie Medicinal Harvest Cup	#1 Overall Cup	BC God Bud
2011	Treating Yourself Medical Cup	#2 Overall Cup	BC Blueberry
2010	Top 10 Strains of the Year	Top Strain	Texada Timewarp
2010	Top 10 Canadian Strains of All Time	Top Strain	The Purps
2010	Top 10 Canadian Strains of All Time	Top Strain	BC God Bud
2009	HighTimes Cannabis Cup	#3 Sativa Cup	The Purps
2009	Top 10 Strains of the Year	Top Strain	BC Mango
2009	Seed Bank Hall of Fame Induction	Hall Of Fame	BC Bud Depot
2008	Top 10 Strains of the Year	Top Strain	The Black
2008	Barcelona Spannabis Cup	Spannabis Cup	The Black
2007	HighTimes Cannabis Cup	#3 Sativa Cup	The Purps
2007	Top 10 Strains of the Year	Top Strain	The Purps
2006	Top 10 Strains of the Year	Top Strain	BC Sweet God
2006	Toronto Cannabis Cup	#2 Overall Cup	BC Sweet God
2005	Top 10 Strains of the Year	Top Strain	BC God Bud
2005	Battle of the Bridges Cup	#1 Overall Cup	BC God Bud
2005	ICMag 420 Hash Cup	#2 Hash Cup	BC God Bud
2004	HighTimes Cannabis Cup	#1 Indica Cup	BC God Bud

 

BCBD has held the inside cover of High Times Magazine for the past ten years and remains among the most recognized names in cannabis genetics and breeding.

 

If all of Matthew Harvey’s convertible securities were converted into common shares of the Company, Matthew Harvey would control 9,900,000 common shares (21.4%) of a total of 46,234,200 fully diluted common shares of the Company.

 

AREV is pleased to announce that BC Bud Depot has won first place for best marijuana strain with BC Sweet God, at the Kootenay Cannabis Cup on August 25th in Cranbrook, BC. The championship win marks the 35th major award for BC Bud Depot since their inaugural first place finish in world competition in the Netherlands in 2004, with BC God Bud, now Canada’s most award-winning strain of all time. Other notable wins include a first place Bio Cannabis Cup in Spain for the Gods Gift strain in 2015, a first place Concentrate Cup for the BC Blueberry strain in California in 2014, and another first place for the Girl Scout Cookies strain at the Medical Cannabis Cup in Los Angeles. BC Bud Depot was inducted into the Seed Bank Hall of Fame by High Times Magazine in 2009. The Kootenay Cannabis Cup marked the third major award for the BC Sweet God strain.

 

“Events like the Kootenay Cannabis Cup bring recognition to the hard work of the many botanical innovators whose marijuana strains drive the industry,” stated Matthew Harvey, BC Bud Depot (BCBD) founder. “The quality of craft cannabis at the Kootenay event was so competitive that this award could have gone to any number of entrants.”

 

As reported on July 12th, 2018, AREV Nutrition Sciences Inc. recently purchased 100% of all assets under the BCBD brand, including existing and future strains. BCBD intends to licence genetics within the Canadian industry, and will directly supply genetic material to licensed producers owned by AREV. As reported August 22nd, AREV will acquire Seventails Cultivation, a Health Canada applicant at the ready-to-inspect stage for a 20,000 square-foot processing and cultivation facility. Laboratory-assisted breeding operations are to be conducted on an acreage owned by AREV in Sorrento, BC.

 

AREV chairman Mike Withrow stated “It is tremendously rewarding to witness the evolution of BC Bud Depot as a company, maintaining a position atop the industry as Canada’s preeminent breeding house, and one of the top few in the world. And in addition to the genetics they breed, the finished quality of the winning marijuana is a testament to the world-class talent of BCBD cultivators. This is the pool of talent available to us for the production of high-end cannabis.”

 

Withrow added, “We anticipate greater price spreads for premium, elite cannabis in years to come, as regulated markets build trust in the supply chain. For us, product quality begins at the genomic level, with the award-winning genetics from BC Bud Depot.”

 

Kootenay organizer Tamara Cartwright reports that the Kootenay Cannabis Cup was a complete success, featuring performers, competition and a product expo. She intends to host competitors at the second annual edition of the event in Cranbrook again next year.

  

Seek safe harbor and forward looking statements.

 

For further information, contact Mike Withrow, mike.withrow.vn@gmail.com.

On behalf of the Board,

 

Mike Withrow
Chairman & Director

About AREV Nutrition Sciences Inc.
AREV Nutrition Sciences Inc. (“AREV”) produces and delivers functional ingredients from its world-class extraction systems. AREV is revolutionizing the current delivery method of coconut oil, whey protein and nutrients through emulsification. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV is also working with Pharmacy and Dispensary operators with an innovative emulsified base formula to disperse Cannabis oil extracts from specific selected genetic Cannabis strains that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido.   

 

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

 

FORWARD LOOKING INFORMATION

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements.  Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on www.sedar.com.